Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Anatara Lifesciences.
RELATED STOCKHEAD STORIES
News
Market Highlights: US GDP boosts market confidence, and 5 ASX small caps to watch today
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ASX Health Stocks: AVITA flies as high as 24pc after providing a big, bullish guidance
News
10 at 11ish: MC Mining bounces on takeover bid, Block rockets
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Benchmark ends an ordinary Monday on a low, despite Dacian’s big gold delivery
Health & Biotech
ASX Health Stocks: Anatara moves rapidly to Stage 2 in Phase 1/2 bowel syndrome trial
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Local markets fall on timid Tuesday but Biotron bets build as investors ask if it’s aced an anti-viral AIDS therapy
Health & Biotech
ASX Health Stocks: Memphasys says Felix can separate sperm better than current techniques
News
Market Highlights: Binance’s CZ sued by SEC, as market awaits RBA decision at 2.30pm
Health & Biotech
ASX Health Stocks: Volpara jumps 10pc as US FDA makes new ruling on ‘dense breasts’ language
News
LAST ORDERS: Today’s semi-serious look at some very serious ASX stuff
Health & Biotech
ASX Health Stocks: Althea to start selling medicinal cannabis in Ireland
Health & Biotech
ASX Health Stocks: Microba is set to enter preclinical assessment as early as this year
Health & Biotech
ASX Health Stocks: CSL drags Healthcare index down 5pc on a mammoth $6.3bn cap raise
News
